Bioqube Ventures is a specialist life sciences investment firm based in Europe with a global footprint. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.
Bioqube Ventures launched its independent fund “Bioqube Factory Fund I” in 2020
… a life sciences venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients. Europe is a proven pool for hidden gems ready to be transformed into international biotechs.
… a fit-for-purpose dual investment model – besides more classical investments in investment rounds, we have special attention for “Create” projects that require additional experiments prior to creating new ventures. With our in-house “factory” model we are able to translate exciting science into trailblazing companies.
… a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. We believe in putting our expertise at work where it matters.
Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer
6 March, 2023
Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform
20 October, 2022